HiDO-ALZ
Asset
Automated medication dispenser with facial recognition and video observation to ensure adherence.
- Stage
- Phase 2
- Modality
- Device
- Target
- Not known
- 4
- Indications
- 1
- Trial
- 1
- Developer
Indications
4Alzheimer's disease
Phase 2, Completed, NCT06691256, clinicaltrials.gov, 8 Oct 2026
Dementia
Phase 2, Completed, NCT06691256, clinicaltrials.gov, 8 Oct 2026
Medication adherence
Phase 2, Completed, NCT06691256, clinicaltrials.gov, 8 Oct 2026
1 more
In the full profile
- Owner and partners1
- Trials1
- Competitors7
- Signals1
Every asset’s record: target, stage, trials and the evidence behind it.